Dominari Holdings Inc. (DOMH)

USD 4.58

(1.1%)

Total Debt Summary of Dominari Holdings Inc.

  • Dominari Holdings Inc.'s latest annual total debt in 2023 was 3.02 Million USD , up 352.62% from previous year.
  • Dominari Holdings Inc.'s latest quarterly total debt in 2024 Q2 was 3.24 Million USD , down -3.11% from previous quarter.
  • Dominari Holdings Inc. reported annual total debt of 762 Thousand USD in 2022, down 0.0% from previous year.
  • Dominari Holdings Inc. reported annual total debt of - USD in 2021, down 0.0% from previous year.
  • Dominari Holdings Inc. reported quarterly total debt of 3.34 Million USD for 2024 Q1, down -2.93% from previous quarter.
  • Dominari Holdings Inc. reported quarterly total debt of 3.61 Million USD for 2023 Q2, up 1.43% from previous quarter.

Annual Total Debt Chart of Dominari Holdings Inc. (2023 - 1989)

Created with Highcharts 11.1.0YearsTotal Debt199019921994199619982000200220042006200820102012201420162018202020220 USD1000000 USD2000000 USD3000000 USD4000000 USD

Historical Annual Total Debt of Dominari Holdings Inc. (2023 - 1989)

Year Total Debt Total Debt Growth
2023 3.02 Million USD 352.62%
2022 762 Thousand USD 0.0%
2021 - USD 0.0%
2020 - USD 0.0%
2019 - USD 0.0%
2018 - USD -100.0%
2017 48 Thousand USD -78.85%
2016 227 Thousand USD -44.23%
2015 407 Thousand USD -29.83%
2014 580 Thousand USD 0.0%
2013 - USD 0.0%
2012 - USD 0.0%
2011 - USD 0.0%
2010 - USD 0.0%
2009 - USD 0.0%
2008 - USD 0.0%
2007 - USD -100.0%
2006 364.19 Thousand USD -75.34%
2005 1.47 Million USD -26.62%
2004 2.01 Million USD 13.05%
2003 1.78 Million USD 118.97%
2002 812.91 Thousand USD 156.4%
2001 317.04 Thousand USD -57.43%
2000 744.68 Thousand USD -72.42%
1999 2.7 Million USD 12.5%
1998 2.4 Million USD 60.0%
1997 1.5 Million USD 650.0%
1996 200 Thousand USD -33.33%
1995 300 Thousand USD -80.0%
1994 1.5 Million USD -11.76%
1993 1.7 Million USD 142.86%
1992 700 Thousand USD -58.82%
1991 1.7 Million USD -10.53%
1990 1.9 Million USD 0.0%
1989 1.9 Million USD 72.73%

Peer Total Debt Comparison of Dominari Holdings Inc.

Name Total Debt Total Debt Difference
Eton Pharmaceuticals, Inc. 5.45 Million USD 44.491%
TRACON Pharmaceuticals, Inc. 968 Thousand USD -212.81%
Vaxxinity, Inc. 15.16 Million USD 80.037%
IO Biotech, Inc. 2.49 Million USD -21.411%
Aridis Pharmaceuticals, Inc. 6.13 Million USD 50.604%
CASI Pharmaceuticals, Inc. 21.23 Million USD 85.743%
MEI Pharma, Inc. - USD -Infinity%
Mersana Therapeutics, Inc. 33.83 Million USD 91.049%
Phathom Pharmaceuticals, Inc. 139.03 Million USD 97.822%
SELLAS Life Sciences Group, Inc. 906 Thousand USD -234.216%
Syndax Pharmaceuticals, Inc. 1.63 Million USD -85.199%
Keros Therapeutics, Inc. 14.44 Million USD 79.036%
Telomir Pharmaceuticals, Inc. Common Stock 101 Thousand USD -2898.02%
Adaptive Biotechnologies Corporation 229.43 Million USD 98.68%
Agenus Inc. 350.24 Million USD 99.135%
AlloVir, Inc. 27.42 Million USD 88.961%
CRISPR Therapeutics AG 238.63 Million USD 98.731%
Xeris Biopharma Holdings, Inc. 229.19 Million USD 98.679%
NextCure, Inc. 6.6 Million USD 54.156%
Opthea Limited 200.62 Million USD 98.491%
Outlook Therapeutics, Inc. 35.55 Million USD 91.484%
Rigel Pharmaceuticals, Inc. 60.57 Million USD 95.002%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Aadi Bioscience, Inc. 7.02 Million USD 56.891%
Senti Biosciences, Inc. 37.66 Million USD 91.961%
Akebia Therapeutics, Inc. 104.18 Million USD 97.094%
Alzamend Neuro, Inc. 300.71 Thousand USD -906.937%
Alnylam Pharmaceuticals, Inc. 2.68 Billion USD 99.887%
BioLineRx Ltd. 11.59 Million USD 73.876%
Compass Therapeutics, Inc. 1.73 Million USD -74.726%
Barinthus Biotherapeutics plc 12.97 Million USD 76.665%
Sensei Biotherapeutics, Inc. 6.2 Million USD 51.224%
Janux Therapeutics, Inc. 24.54 Million USD 87.662%
Verrica Pharmaceuticals Inc. 45.51 Million USD 93.347%
AbCellera Biologics Inc. 77.38 Million USD 96.087%
ADMA Biologics, Inc. 141.41 Million USD 97.859%
Aptorum Group Limited 3.36 Million USD 9.945%
AnaptysBio, Inc. 17.81 Million USD 83.002%
Ardelyx, Inc. 55.98 Million USD 94.591%
Arrowhead Pharmaceuticals, Inc. 115.17 Million USD 97.371%
Bicycle Therapeutics plc 44.95 Million USD 93.265%
BioXcel Therapeutics, Inc. 101.38 Million USD 97.013%
C4 Therapeutics, Inc. 70.97 Million USD 95.734%
Clearside Biomedical, Inc. 43 Million USD 92.958%
Chimerix, Inc. 2.14 Million USD -41.231%
Corbus Pharmaceuticals Holdings, Inc. 20.88 Million USD 85.501%
Dyadic International, Inc. 136.92 Thousand USD -2111.365%
Elevation Oncology, Inc. 30.13 Million USD 89.953%
ESSA Pharma Inc. 80.32 Thousand USD -3669.545%
Fortress Biotech, Inc. 88.59 Million USD 96.582%
Fate Therapeutics, Inc. 103.53 Million USD 97.075%
GlycoMimetics, Inc. 808.4 Thousand USD -274.566%
Fortress Biotech, Inc. 88.59 Million USD 96.582%
ChromaDex Corporation 3.27 Million USD 7.598%
Hoth Therapeutics, Inc. 55.16 Thousand USD -5388.988%
CARGO Therapeutics, Inc. Common Stock 28.54 Million USD 89.391%
Caribou Biosciences, Inc. 27.48 Million USD 88.983%
IDEAYA Biosciences, Inc. 2.87 Million USD -5.432%
Inhibrx Biosciences, Inc. 210.14 Million USD 98.559%
Incyte Corporation 38.28 Million USD 92.091%
Inovio Pharmaceuticals, Inc. 30.2 Million USD 89.977%
Intensity Therapeutics, Inc. 158 Thousand USD -1816.456%
Jaguar Health, Inc. 35.86 Million USD 91.556%
Jazz Pharmaceuticals plc 5.79 Billion USD 99.948%
Kintara Therapeutics, Inc. - USD -Infinity%
Ligand Pharmaceuticals Incorporated 6.16 Million USD 50.884%
ContextLogic Inc. 6 Million USD 49.533%
Lantern Pharma Inc. 234.47 Thousand USD -1191.418%
Madrigal Pharmaceuticals, Inc. 117.19 Million USD 97.416%
MiMedx Group, Inc. 48.09 Million USD 93.705%
Marinus Pharmaceuticals, Inc. 110.35 Million USD 97.256%
Structure Therapeutics Inc. 5.45 Million USD 44.471%
HOOKIPA Pharma Inc. 6.55 Million USD 53.834%
Onconetix, Inc. 9.88 Million USD 69.37%
Oncternal Therapeutics, Inc. 318 Thousand USD -852.201%
Psyence Biomedical Ltd. 7.65 Million USD 60.457%
PDS Biotechnology Corporation 23.85 Million USD 87.305%
Precigen, Inc. 7.09 Million USD 57.334%
Pharming Group N.V. 171.54 Million USD 98.235%
Pieris Pharmaceuticals, Inc. - USD -Infinity%
PureTech Health plc 25.51 Million USD 88.131%
RAPT Therapeutics, Inc. 6.9 Million USD 56.154%
Royalty Pharma plc 6.13 Billion USD 99.951%
Reviva Pharmaceuticals Holdings, Inc. - USD -Infinity%
Seer, Inc. 28.25 Million USD 89.285%
Sangamo Therapeutics, Inc. 38.1 Million USD 92.053%
Sol-Gel Technologies Ltd. 1.65 Million USD -83.182%
Acelyrin, Inc. 1.19 Million USD -153.601%
Salarius Pharmaceuticals, Inc. 289.64 Thousand USD -945.425%
Pyxis Oncology, Inc. 21.33 Million USD 85.805%
TransCode Therapeutics, Inc. 450.57 Thousand USD -572.036%
Syros Pharmaceuticals, Inc. 62.07 Million USD 95.122%
TG Therapeutics, Inc. 110.79 Million USD 97.267%
Alkermes plc 290.73 Million USD 98.958%
Entrada Therapeutics, Inc. 68.23 Million USD 95.562%
Titan Pharmaceuticals, Inc. 565 Thousand USD -435.929%
Orchestra BioMed Holdings, Inc. 1.68 Million USD -79.49%
Ocuphire Pharma, Inc. - USD -Infinity%
VistaGen Therapeutics, Inc. 2.12 Million USD -42.83%
Wave Life Sciences Ltd. 32.11 Million USD 90.572%
Avidity Biosciences, Inc. 9.85 Million USD 69.265%
Geron Corporation 85.89 Million USD 96.475%
Windtree Therapeutics, Inc. 16.83 Million USD 82.008%
Summit Therapeutics Inc. 106.09 Million USD 97.146%
Stoke Therapeutics, Inc. 6.83 Million USD 55.699%
Alaunos Therapeutics, Inc. - USD -Infinity%
Inhibikase Therapeutics, Inc. 622 Thousand USD -386.814%
Innoviva, Inc. 449.07 Million USD 99.326%
Longboard Pharmaceuticals, Inc. 475 Thousand USD -537.474%
Vaxcyte, Inc. 29.22 Million USD 89.639%
Molecular Templates, Inc. 12.23 Million USD 75.241%
VYNE Therapeutics Inc. 214 Thousand USD -1314.953%
Sorrento Therapeutics, Inc. 134.5 Million USD 97.749%
Viracta Therapeutics, Inc. 25.55 Million USD 88.152%
Novavax, Inc. 280.63 Million USD 98.921%
eFFECTOR Therapeutics, Inc. 19.44 Million USD 84.428%
Scopus BioPharma Inc. - USD -Infinity%
Catalyst Pharmaceuticals, Inc. 3.55 Million USD 14.872%
Precision BioSciences, Inc. 31.26 Million USD 90.316%
GT Biopharma, Inc. 58 Thousand USD -5120.69%
ImmuCell Corporation 11.96 Million USD 74.702%
Immix Biopharma, Inc. - USD -Infinity%
Mesoblast Limited 118.92 Million USD 97.454%
Rocket Pharmaceuticals, Inc. 25.04 Million USD 87.908%
Aptose Biosciences Inc. 1 Million USD -199.86%
ZyVersa Therapeutics, Inc. 8656.00 USD -34881.516%
Soligenix, Inc. 3.49 Million USD 13.351%
Century Therapeutics, Inc. 48.17 Million USD 93.714%
Kura Oncology, Inc. 17.2 Million USD 82.395%
TScan Therapeutics, Inc. 92.43 Million USD 96.724%
Ocean Biomedical, Inc. 2.15 Million USD -40.837%
CytomX Therapeutics, Inc. 13.97 Million USD 78.331%
Autolus Therapeutics plc 52.96 Million USD 94.283%
Mineralys Therapeutics, Inc. - USD -Infinity%
EyePoint Pharmaceuticals, Inc. 5.46 Million USD 44.633%
Eterna Therapeutics Inc. 41.84 Million USD 92.763%
GRI Bio, Inc. 14 Thousand USD -21528.571%
Xenetic Biosciences, Inc. - USD -Infinity%
Tenaya Therapeutics, Inc. 12.42 Million USD 75.628%
IGM Biosciences, Inc. 40.5 Million USD 92.525%
INmune Bio, Inc. 10.43 Million USD 70.988%
Heron Therapeutics, Inc. 179.62 Million USD 98.314%
SAB Biotherapeutics, Inc. 5.9 Million USD 48.739%
Pasithea Therapeutics Corp. 81.68 Thousand USD -3607.15%
Entero Therapeutics, Inc. 826.84 Thousand USD -266.212%
Milestone Pharmaceuticals Inc. 51.77 Million USD 94.152%
X4 Pharmaceuticals, Inc. 58.28 Million USD 94.804%
Atara Biotherapeutics, Inc. 57.87 Million USD 94.768%
Coherus BioSciences, Inc. 480.84 Million USD 99.37%
Verastem, Inc. 41.55 Million USD 92.714%
Abeona Therapeutics Inc. 5.4 Million USD 43.926%
Pliant Therapeutics, Inc. 11.37 Million USD 73.373%
Tonix Pharmaceuticals Holding Corp. 9.81 Million USD 69.143%
Histogen Inc. 4.62 Million USD 34.487%
Aprea Therapeutics, Inc. - USD -Infinity%
Surrozen, Inc. 3.37 Million USD 10.388%
Organovo Holdings, Inc. 1.39 Million USD -117.217%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Ovid Therapeutics Inc. 46 Million USD 93.418%
Panbela Therapeutics, Inc. 5.19 Million USD 41.702%
Cadrenal Therapeutics, Inc. Common Stock 21.35 Thousand USD -14082.67%
Centessa Pharmaceuticals plc 84.58 Million USD 96.42%
Hepion Pharmaceuticals, Inc. 209.02 Thousand USD -1348.665%
Arcturus Therapeutics Holdings Inc. 30.21 Million USD 89.979%
BioRestorative Therapies, Inc. 162.31 Thousand USD -1765.485%
Apollomics, Inc. 4.66 Million USD 35.035%
Amarin Corporation plc 8.73 Million USD 65.343%
Turnstone Biologics Corp. 3.21 Million USD 5.787%
Kymera Therapeutics, Inc. 84.67 Million USD 96.424%
Synaptogenix, Inc. - USD -Infinity%
Tiziana Life Sciences Ltd 247 Thousand USD -1125.911%
Aurinia Pharmaceuticals Inc. 97.6 Million USD 96.898%
BriaCell Therapeutics Corp. - USD -Infinity%
Monopar Therapeutics Inc. - USD -Infinity%
Exelixis, Inc. 189.94 Million USD 98.406%
Better Therapeutics, Inc. 14.88 Million USD 79.651%
Nurix Therapeutics, Inc. 30.61 Million USD 90.109%
Apellis Pharmaceuticals, Inc. 110.92 Million USD 97.27%
NLS Pharmaceutics AG 1.63 Million USD -85.341%
Dermata Therapeutics, Inc. - USD -Infinity%
Gritstone bio, Inc. 104.77 Million USD 97.11%
Jasper Therapeutics, Inc. 2.78 Million USD -8.686%
TNF Pharmaceuticals, Inc. 48.87 Thousand USD -6096.03%
Avid Bioservices, Inc. 207.83 Million USD 98.543%
Insmed Incorporated 1.2 Billion USD 99.749%
Virpax Pharmaceuticals, Inc. - USD -Infinity%
MediWound Ltd. 6.71 Million USD 54.88%
OmniAb, Inc. 25.56 Million USD 88.154%
Alector, Inc. 38.91 Million USD 92.22%
Seres Therapeutics, Inc. 213.93 Million USD 98.585%
Checkpoint Therapeutics, Inc. - USD -Infinity%
Zai Lab Limited 15.15 Million USD 80.015%
Revance Therapeutics, Inc. 478.43 Million USD 99.367%
Aura Biosciences, Inc. 19.55 Million USD 84.517%
Lyell Immunopharma, Inc. 63.16 Million USD 95.206%
Immunic, Inc. 1.33 Million USD -126.987%
Tarsus Pharmaceuticals, Inc. 31.73 Million USD 90.458%
Veracyte, Inc. 12.63 Million USD 76.025%
InMed Pharmaceuticals Inc. 644.86 Million USD 99.53%
FibroGen, Inc. 170.45 Million USD 98.224%
SeaStar Medical Holding Corporation 9.08 Million USD 66.656%
Adial Pharmaceuticals, Inc. - USD -Infinity%
Sonnet BioTherapeutics Holdings, Inc. 203.91 Thousand USD -1384.962%
Cyclacel Pharmaceuticals, Inc. 37 Thousand USD -8083.784%
Amylyx Pharmaceuticals, Inc. 4.23 Million USD 28.534%
Galecto, Inc. 249 Thousand USD -1116.064%
Calithera Biosciences, Inc. 1.66 Million USD -81.753%
Fortrea Holdings Inc. 1.67 Billion USD 99.82%
KalVista Pharmaceuticals, Inc. 7.31 Million USD 58.617%
Aptevo Therapeutics Inc. 5.39 Million USD 43.895%
XBiotech Inc. - USD -Infinity%
Jasper Therapeutics, Inc. 2.78 Million USD -8.686%
Lyra Therapeutics, Inc. 26.88 Million USD 88.736%
Foghorn Therapeutics Inc. 45.07 Million USD 93.282%
Y-mAbs Therapeutics, Inc. 1.41 Million USD -113.39%
Theravance Biopharma, Inc. 45.23 Million USD 93.306%
Ultragenyx Pharmaceutical Inc. 43.16 Million USD 92.986%
Metagenomi, Inc. Common Stock 48.22 Million USD 93.722%
BioCryst Pharmaceuticals, Inc. 848.71 Million USD 99.643%
Gain Therapeutics, Inc. 1.02 Million USD -194.725%
Cartesian Therapeutics, Inc. 10.95 Million USD 72.36%
NexImmune, Inc. 68.8 Thousand USD -4300.587%
Creative Medical Technology Holdings, Inc. 14.19 Thousand USD -21232.958%
Marker Therapeutics, Inc. - USD -Infinity%
Regeneron Pharmaceuticals, Inc. 2.7 Billion USD 99.888%
Chemomab Therapeutics Ltd. 392 Thousand USD -672.445%
Ainos, Inc. 5.96 Million USD 49.225%
Pluri Inc. 29.61 Million USD 89.774%
Prothena Corporation plc 11.83 Million USD 74.415%
Adaptimmune Therapeutics plc 25.23 Million USD 88.001%
Celularity Inc. 65.41 Million USD 95.371%
Rallybio Corporation 392 Thousand USD -672.449%
Cue Biopharma, Inc. 14.69 Million USD 79.394%
MeiraGTx Holdings plc 89.26 Million USD 96.608%
Omeros Corporation 338.28 Million USD 99.105%
Humacyte, Inc. 58.1 Million USD 94.789%
Immunocore Holdings plc 84.03 Million USD 96.397%
Cocrystal Pharma, Inc. 1.85 Million USD -63.411%
Cidara Therapeutics, Inc. 4.87 Million USD 37.913%
Blueprint Medicines Corporation 774.12 Million USD 99.609%
CalciMedica, Inc. - USD -Infinity%
Cabaletta Bio, Inc. 5.01 Million USD 39.657%
Scholar Rock Holding Corporation 61.81 Million USD 95.102%
Sana Biotechnology, Inc. 104.09 Million USD 97.091%
Pulmatrix, Inc. 8.75 Million USD 65.418%
Elicio Therapeutics, Inc. 6.91 Million USD 56.224%
Vigil Neuroscience, Inc. 13.85 Million USD 78.137%
Intellia Therapeutics, Inc. 115.34 Million USD 97.375%
Adlai Nortye Ltd. American Depositary Shares 31.54 Million USD 90.402%
Cytokinetics, Incorporated 755.77 Million USD 99.599%
Eloxx Pharmaceuticals, Inc. 13.38 Million USD 77.376%
Nutriband Inc. 241.28 Thousand USD -1154.947%
Protara Therapeutics, Inc. 5.46 Million USD 44.613%
Vor Biopharma Inc. 35.66 Million USD 91.509%
Roivant Sciences Ltd. 499.74 Million USD 99.394%
Evogene Ltd. 1.13 Million USD -166.081%
ProKidney Corp. 4.41 Million USD 31.385%
Applied Therapeutics, Inc. 1.22 Million USD -146.982%
BridgeBio Pharma, Inc. 1.73 Billion USD 99.826%
CorMedix Inc. 667.63 Thousand USD -353.543%
Tango Therapeutics, Inc. 38.92 Million USD 92.22%
Galectin Therapeutics Inc. 71.8 Million USD 95.783%
Atai Life Sciences N.V. 16.47 Million USD 81.622%
Renovaro Biosciences Inc. 2.45 Million USD -23.542%
Aerovate Therapeutics, Inc. 675 Thousand USD -348.593%
Zentalis Pharmaceuticals, Inc. 45.77 Million USD 93.385%
Sagimet Biosciences Inc. 65 Thousand USD -4558.462%
MediciNova, Inc. 215.92 Thousand USD -1302.332%
Praxis Precision Medicines, Inc. 2.49 Million USD -21.363%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD -140.122%
GeoVax Labs, Inc. - USD -Infinity%
Axsome Therapeutics, Inc. 186.37 Million USD 98.375%
Biomea Fusion, Inc. 10.29 Million USD 70.591%
PTC Therapeutics, Inc. 415.02 Million USD 99.27%
Mereo BioPharma Group plc 5.95 Million USD 49.126%
Cullinan Oncology, Inc. 3.59 Million USD 15.655%
Absci Corporation 15.95 Million USD 81.024%
NRx Pharmaceuticals, Inc. 9.16 Million USD 66.947%
4D Molecular Therapeutics, Inc. 14.67 Million USD 79.361%
Dyne Therapeutics, Inc. 27.41 Million USD 88.955%
Kiniksa Pharmaceuticals, Ltd. 12.25 Million USD 75.298%
Ventyx Biosciences, Inc. 12.5 Million USD 75.788%
Allakos Inc. 41.46 Million USD 92.697%
Imunon, Inc. 1.62 Million USD -86.371%
Fulcrum Therapeutics, Inc. 10.82 Million USD 72.017%
Corcept Therapeutics Incorporated 151 Thousand USD -1905.298%
BioAtla, Inc. 2.46 Million USD -23.089%
NLS Pharmaceutics AG 1.63 Million USD -85.341%
Bio-Path Holdings, Inc. 113 Thousand USD -2579.646%
Allogene Therapeutics, Inc. 95.12 Million USD 96.817%
Larimar Therapeutics, Inc. 5.54 Million USD 45.402%
XOMA Corporation 124.45 Million USD 97.567%
Kezar Life Sciences, Inc. 18.93 Million USD 84.007%
Cara Therapeutics, Inc. 43.16 Million USD 92.985%
aTyr Pharma, Inc. 15.09 Million USD 79.94%
Aligos Therapeutics, Inc. 11.13 Million USD 72.814%
Akero Therapeutics, Inc. 26.04 Million USD 88.373%
Viridian Therapeutics, Inc. 21.04 Million USD 85.614%
Eliem Therapeutics, Inc. 349 Thousand USD -767.622%
EyeGate Pharmaceuticals, Inc. 326.49 Thousand USD -827.432%
Akari Therapeutics, Plc - USD -Infinity%
Tevogen Bio Holdings Inc. 1.63 Million USD -85.57%
Halozyme Therapeutics, Inc. 1.49 Billion USD 99.798%
Lexaria Bioscience Corp. 163.96 Thousand USD -1746.713%
UroGen Pharma Ltd. 100.21 Million USD 96.978%
Sutro Biopharma, Inc. 182.74 Million USD 98.343%
ZIVO Bioscience, Inc. 346.34 Thousand USD -774.28%
Orgenesis Inc. 22.62 Million USD 86.614%
Entera Bio Ltd. 390 Thousand USD -676.41%
GH Research PLC 343 Thousand USD -782.799%
Lisata Therapeutics, Inc. 305 Thousand USD -892.787%
Reneo Pharmaceuticals, Inc. 973 Thousand USD -211.202%
Xencor, Inc. 83.43 Million USD 96.371%
60 Degrees Pharmaceuticals, Inc. 172.67 Thousand USD -1653.604%
Replimune Group, Inc. 75.86 Million USD 96.009%
Coeptis Therapeutics Holdings, Inc. 1.22 Million USD -147.34%
Vanda Pharmaceuticals Inc. 9.4 Million USD 67.801%
Lexaria Bioscience Corp. 163.96 Thousand USD -1746.713%
Portage Biotech Inc. 47 Thousand USD -6342.553%
Cardio Diagnostics Holdings, Inc. 1.26 Million USD -140.122%
Olema Pharmaceuticals, Inc. 2.41 Million USD -25.279%
OncoCyte Corporation 2.86 Million USD -5.542%
Qualigen Therapeutics, Inc. 1.29 Million USD -133.064%
Processa Pharmaceuticals, Inc. 150.55 Thousand USD -1911.238%
Purple Biotech Ltd. 351 Thousand USD -762.678%
CollPlant Biotechnologies Ltd. 3.15 Million USD 4.147%
scPharmaceuticals Inc. 40.26 Million USD 92.481%
ProMIS Neurosciences, Inc. - USD -Infinity%
HilleVax, Inc. 51.19 Million USD 94.085%
NeuroSense Therapeutics Ltd. 142 Thousand USD -2032.394%
Tharimmune, Inc. - USD -Infinity%
Genprex, Inc. - USD -Infinity%
Neumora Therapeutics, Inc. Common Stock 5.23 Million USD 42.114%
Atossa Therapeutics, Inc. - USD -Infinity%
XTL Biopharmaceuticals Ltd. - USD -Infinity%
Virios Therapeutics, Inc. - USD -Infinity%
OKYO Pharma Limited - USD -Infinity%
Savara Inc. 26.73 Million USD 88.675%
Curis, Inc. 2.79 Million USD -8.375%
Daré Bioscience, Inc. 5.31 Million USD 43.063%
Carmell Therapeutics Corporation 2.13 Million USD -41.731%
Achieve Life Sciences, Inc. 16.73 Million USD 81.902%
BeiGene, Ltd. 930.18 Million USD 99.674%
Kiromic BioPharma, Inc. 15.54 Million USD 80.518%
Revolution Medicines, Inc. Warrant 87.94 Million USD 96.557%
Protagonist Therapeutics, Inc. 1.14 Million USD -165.381%
Erasca, Inc. 55.85 Million USD 94.579%
bluebird bio, Inc. 330.32 Million USD 99.083%
Protagenic Therapeutics, Inc. - USD -Infinity%
BioMarin Pharmaceutical Inc. 1.13 Billion USD 99.733%
DBV Technologies S.A. 14.38 Million USD 78.944%
Protagenic Therapeutics, Inc. - USD -Infinity%
Moderna, Inc. - USD -Infinity%
Vincerx Pharma, Inc. 2.5 Million USD -21.023%
Fresh Tracks Therapeutics, Inc. - USD -Infinity%
Acrivon Therapeutics, Inc. Common Stock 4.64 Million USD 34.798%
Travere Therapeutics, Inc. 404.78 Million USD 99.252%
Monte Rosa Therapeutics, Inc. 46.03 Million USD 93.423%
Spruce Biosciences, Inc. 4.6 Million USD 34.302%
Celldex Therapeutics, Inc. 2.54 Million USD -19.119%
Cogent Biosciences, Inc. 18.85 Million USD 83.939%
MacroGenics, Inc. 33.97 Million USD 91.087%
RenovoRx, Inc. - USD -Infinity%
Adicet Bio, Inc. 20.92 Million USD 85.529%
Prime Medicine, Inc. 13.63 Million USD 77.789%
Aditxt, Inc. 18.21 Million USD 83.379%
Adagene Inc. 22.3 Million USD 86.426%
Estrella Immunopharma, Inc. - USD -Infinity%
Quantum-Si incorporated 15.3 Million USD 80.213%
Maravai LifeSciences Holdings, Inc. 610.96 Million USD 99.504%
Acurx Pharmaceuticals, Inc. - USD -Infinity%
Voyager Therapeutics, Inc. 20.29 Million USD 85.079%
SciSparc Ltd. 76 Thousand USD -3884.211%
Vericel Corporation 88.14 Million USD 96.565%
Revelation Biosciences, Inc. - USD -Infinity%
Minerva Neurosciences, Inc. 82.01 Million USD 96.308%
Generation Bio Co. 97.89 Million USD 96.907%
Astria Therapeutics, Inc. 329 Thousand USD -820.365%
Black Diamond Therapeutics, Inc. 25.29 Million USD 88.031%
Arcutis Biotherapeutics, Inc. 205.91 Million USD 98.529%
Invivyd, Inc. 2.16 Million USD -39.861%
Relay Therapeutics, Inc. 53.46 Million USD 94.337%
Quoin Pharmaceuticals, Ltd. 3523.73 USD -85831.669%
Spero Therapeutics, Inc. 5.54 Million USD 45.373%
Artelo Biosciences, Inc. 63 Thousand USD -4706.349%
2seventy bio, Inc. 256.67 Million USD 98.82%
Clene Inc. 32.16 Million USD 90.585%
Capricor Therapeutics, Inc. 5.61 Million USD 46.046%
Boundless Bio, Inc. Common Stock 2.19 Million USD -37.95%
GeoVax Labs, Inc. - USD -Infinity%
Recursion Pharmaceuticals, Inc. 50.67 Million USD 94.024%
Citius Pharmaceuticals, Inc. 481.24 Thousand USD -529.201%
Contineum Therapeutics, Inc. Class A Common Stock 193.19 Million USD 98.433%
Relmada Therapeutics, Inc. - USD -Infinity%
Finch Therapeutics Group, Inc. 30.12 Million USD 89.949%
ALX Oncology Holdings Inc. 17.19 Million USD 82.392%
Vir Biotechnology, Inc. 124.54 Million USD 97.569%
Evaxion Biotech A/S 10.86 Million USD 72.143%
Ocular Therapeutix, Inc. 83.38 Million USD 96.369%
Verve Therapeutics, Inc. 74.9 Million USD 95.958%
Trevena, Inc. 35.23 Million USD 91.406%
Surrozen, Inc. 3.37 Million USD 10.388%
Tyra Biosciences, Inc. 6.49 Million USD 53.387%
Cingulate Inc. 3.13 Million USD 3.416%
Galmed Pharmaceuticals Ltd. 41 Thousand USD -7285.366%
Unity Biotechnology, Inc. 26.99 Million USD 88.781%
Tenax Therapeutics, Inc. 500.9 Thousand USD -504.508%
Terns Pharmaceuticals, Inc. 603 Thousand USD -402.156%
ACADIA Pharmaceuticals Inc. 57.2 Million USD 94.707%
Connect Biopharma Holdings Limited 465 Thousand USD -551.183%
Clearmind Medicine Inc. - USD -Infinity%
Kronos Bio, Inc. 28.27 Million USD 89.29%
Bolt Biotherapeutics, Inc. 20.21 Million USD 85.024%
CERo Therapeutics Holdings, Inc. 1.55 Million USD -94.727%
Viking Therapeutics, Inc. 1.26 Million USD -140.317%
Statera Biopharma, Inc. 16.26 Million USD 81.379%
ImmunityBio, Inc. 883.67 Million USD 99.657%
Korro Bio, Inc. 33.2 Million USD 90.881%
Kineta, Inc. 1.31 Million USD -129.916%
BioVie Inc. 6.11 Million USD 50.454%
Codexis, Inc. 22.36 Million USD 86.46%
Celularity Inc. 65.41 Million USD 95.371%
Crinetics Pharmaceuticals, Inc. 51.72 Million USD 94.146%
Celcuity Inc. 37.44 Million USD 91.914%
Virax Biolabs Group Limited 224.3 Thousand USD -1249.978%
Cibus, Inc. 24.62 Million USD 87.702%
Eledon Pharmaceuticals, Inc. 383 Thousand USD -690.601%
IN8bio, Inc. 4.89 Million USD 38.116%
Kodiak Sciences Inc. 181.63 Million USD 98.333%
Annexon, Inc. 31.35 Million USD 90.343%
Adverum Biotechnologies, Inc. 75.03 Million USD 95.965%
Assembly Biosciences, Inc. 2.34 Million USD -29.291%
Avalo Therapeutics, Inc. 3.9 Million USD 22.419%
Ionis Pharmaceuticals, Inc. 1.45 Billion USD 99.792%
Eyenovia, Inc. 16.1 Million USD 81.202%
Puma Biotechnology, Inc. 111.49 Million USD 97.284%
Conduit Pharmaceuticals Inc. 985 Thousand USD -207.411%
Xilio Therapeutics, Inc. 11.45 Million USD 73.571%
Arcellx, Inc. 97.62 Million USD 96.898%
Cardiff Oncology, Inc. 2.14 Million USD -40.903%
Enanta Pharmaceuticals, Inc. 26.51 Million USD 88.579%
Regulus Therapeutics Inc. 3.1 Million USD 2.386%
Moolec Science SA 2.64 Million USD -14.468%
Acumen Pharmaceuticals, Inc. 28.48 Million USD 89.371%
LAVA Therapeutics N.V. 6.31 Million USD 52.035%
Atea Pharmaceuticals, Inc. 2.4 Million USD -26.062%
Greenwich LifeSciences, Inc. - USD -Infinity%
TFF Pharmaceuticals, Inc. 115.25 Thousand USD -2527.241%
Humacyte, Inc. 58.1 Million USD 94.789%
89bio, Inc. 27.1 Million USD 88.83%
PMV Pharmaceuticals, Inc. 13.28 Million USD 77.209%
Avenue Therapeutics, Inc. - USD -Infinity%
Genelux Corporation 2.51 Million USD -20.206%
Trevi Therapeutics, Inc. 1.33 Million USD -126.308%
Lexicon Pharmaceuticals, Inc. 106.06 Million USD 97.145%
Notable Labs, Ltd. 2.04 Million USD -47.779%
Liquidia Corporation 3.5 Million USD 13.56%
Mustang Bio, Inc. 2.49 Million USD -21.217%
Immunovant, Inc. 138 Thousand USD -2094.203%
Quantum-Si incorporated 15.3 Million USD 80.213%
Arbutus Biopharma Corporation 8.72 Million USD 65.279%
DiaMedica Therapeutics Inc. 400 Thousand USD -657.0%
Vera Therapeutics, Inc. 53.7 Million USD 94.362%
Acasti Pharma Inc. - USD -Infinity%
MiNK Therapeutics, Inc. - USD -Infinity%
Pasithea Therapeutics Corp. 81.68 Thousand USD -3607.15%
Xenon Pharmaceuticals Inc. 10.9 Million USD 72.228%
Elevai Labs, Inc. Common Stock 210.48 Thousand USD -1338.555%
NeuroBo Pharmaceuticals, Inc. 203 Thousand USD -1391.626%
Tempest Therapeutics, Inc. 20.66 Million USD 85.344%
Soleno Therapeutics, Inc. 403 Thousand USD -651.365%
PepGen Inc. 20.1 Million USD 84.938%
Moleculin Biotech, Inc. 574 Thousand USD -427.526%
United Therapeutics Corporation 700 Million USD 99.567%
Nuvectis Pharma, Inc. - USD -Infinity%
Solid Biosciences Inc. 26.26 Million USD 88.471%
BriaCell Therapeutics Corp. - USD -Infinity%
Immuneering Corporation 4.46 Million USD 32.153%
Lixte Biotechnology Holdings, Inc. - USD -Infinity%
Silo Pharma, Inc. - USD -Infinity%
Belite Bio, Inc 886 Thousand USD -241.761%
XOMA Corporation 124.45 Million USD 97.567%
ARS Pharmaceuticals, Inc. 274 Thousand USD -1005.109%
Bionomics Limited 239.61 Million USD 98.736%
Apogee Therapeutics, Inc. 2.03 Million USD -48.869%
Alpha Tau Medical Ltd. 13.27 Million USD 77.192%
uniQure N.V. 138.4 Million USD 97.812%
Cassava Sciences, Inc. - USD -Infinity%
Estrella Immunopharma, Inc. - USD -Infinity%
Poseida Therapeutics, Inc. 85.42 Million USD 96.455%
Forte Biosciences, Inc. - USD -Infinity%
Anebulo Pharmaceuticals, Inc. - USD -Infinity%
Enlivex Therapeutics Ltd. 1.03 Million USD -193.411%
Conduit Pharmaceuticals Inc. 985 Thousand USD -207.411%
SeaStar Medical Holding Corporation 9.08 Million USD 66.656%
FibroBiologics, Inc. Common Stock 1.74 Million USD -73.326%
Altimmune, Inc. 671 Thousand USD -351.267%
Amicus Therapeutics, Inc. 445.05 Million USD 99.32%
Alpha Tau Medical Ltd. 13.27 Million USD 77.192%
Compugen Ltd. 1.35 Million USD -124.13%
Peak Bio, Inc. 10.72 Million USD 71.758%
Zevra Therapeutics, Inc. 42.76 Million USD 92.92%
Benitec Biopharma Inc. 284 Thousand USD -966.197%
Spyre Therapeutics, Inc. 84.55 Million USD 96.419%
NKGen Biotech, Inc. Common Stock 19.92 Million USD 84.8%
Zura Bio Limited - USD -Infinity%
PolyPid Ltd. 11.77 Million USD 74.293%
Aileron Therapeutics, Inc. 91.45 Million USD 96.689%
NKGen Biotech, Inc. Warrants 19.92 Million USD 84.8%
Instil Bio, Inc. 86.05 Million USD 96.481%
argenx SE 20 Million USD 84.86%
Immunome, Inc. 1.65 Million USD -83.515%
Verona Pharma plc 51.32 Million USD 94.101%
enGene Holdings Inc. Warrants 9.77 Million USD 69.033%
Shattuck Labs, Inc. 4.2 Million USD 27.939%
CervoMed Inc. - USD -Infinity%
LENZ Therapeutics, Inc. 362 Thousand USD -736.464%
Plus Therapeutics, Inc. 4.18 Million USD 27.577%
Dianthus Therapeutics, Inc. 585 Thousand USD -417.607%
Moolec Science SA 2.64 Million USD -14.468%
Enveric Biosciences, Inc. - USD -Infinity%
Design Therapeutics, Inc. 3.05 Million USD 0.721%
Leap Therapeutics, Inc. 262 Thousand USD -1055.725%
NeurAxis, Inc. 224.26 Thousand USD -1250.218%
Seelos Therapeutics, Inc. 14.22 Million USD 78.718%
Lumos Pharma, Inc. 6.58 Million USD 54.017%
Achilles Therapeutics plc 4.61 Million USD 34.388%
enGene Holdings Inc. Common Stock 9.77 Million USD 69.033%
180 Life Sciences Corp. 1.32 Million USD -129.382%
Opiant Pharmaceuticals, Inc. 17.08 Million USD 82.272%
CERo Therapeutics Holdings, Inc. 1.55 Million USD -94.727%
Nutriband Inc. 241.28 Thousand USD -1154.947%
ORIC Pharmaceuticals, Inc. 10.21 Million USD 70.352%
CG Oncology, Inc. Common stock 826 Thousand USD -266.586%
Fractyl Health, Inc. Common Stock 373.72 Million USD 99.19%
Rani Therapeutics Holdings, Inc. 30.09 Million USD 89.94%
MoonLake Immunotherapeutics 3.69 Million USD 18.115%
Palisade Bio, Inc. 369 Thousand USD -720.596%
Tourmaline Bio, Inc. 415 Thousand USD -629.639%
Beam Therapeutics Inc. 173.17 Million USD 98.251%
Neurogene Inc. 16.25 Million USD 81.372%
Mirum Pharmaceuticals, Inc. 308.14 Million USD 99.017%
AEON Biopharma, Inc. 278 Thousand USD -989.209%
Sesen Bio, Inc. - USD -Infinity%
Enliven Therapeutics, Inc. 335 Thousand USD -803.881%
Kiora Pharmaceuticals, Inc. 106.89 Thousand USD -2732.792%
Iovance Biotherapeutics, Inc. 75.86 Million USD 96.009%
Taysha Gene Therapies, Inc. 61.1 Million USD 95.045%
Athira Pharma, Inc. 1.58 Million USD -91.041%
Vaccinex, Inc. 247 Thousand USD -1125.911%
HCW Biologics Inc. 6.45 Million USD 53.067%
XOMA Corporation 124.45 Million USD 97.567%
Nektar Therapeutics 230.4 Million USD 98.686%
Arvinas, Inc. 3.4 Million USD 10.941%
Tevogen Bio Holdings Inc. 1.63 Million USD -85.57%
Merus N.V. 12.16 Million USD 75.103%
Omega Therapeutics, Inc. 128.42 Million USD 97.642%
Quince Therapeutics, Inc. 13.81 Million USD 78.08%
Rezolute, Inc. 2.22 Million USD -35.907%
Clene Inc. 32.16 Million USD 90.585%
Indaptus Therapeutics, Inc. 175.05 Thousand USD -1629.762%
BeyondSpring Inc. 3.99 Million USD 24.205%
Synlogic, Inc. 17.27 Million USD 82.472%
Allarity Therapeutics, Inc. 1.3 Million USD -132.923%
Phio Pharmaceuticals Corp. 35 Thousand USD -8551.429%
Peak Bio, Inc. 10.72 Million USD 71.758%
Werewolf Therapeutics, Inc. 51.92 Million USD 94.168%
Krystal Biotech, Inc. 8.09 Million USD 62.59%
Karyopharm Therapeutics Inc. 177.01 Million USD 98.289%
SpringWorks Therapeutics, Inc. 7.05 Million USD 57.092%
Lipella Pharmaceuticals Inc. 136.59 Thousand USD -2116.788%
MannKind Corporation 382.37 Million USD 99.208%
Ikena Oncology, Inc. 10.73 Million USD 71.801%
Cyclerion Therapeutics, Inc. - USD -Infinity%
Gyre Therapeutics, Inc. 409 Thousand USD -640.342%
Gossamer Bio, Inc. 212.46 Million USD 98.575%
CohBar, Inc. - USD -Infinity%
Cognition Therapeutics, Inc. 174 Thousand USD -1640.23%
NRx Pharmaceuticals, Inc. 9.16 Million USD 66.947%
Legend Biotech Corporation 328.67 Million USD 99.079%
Mural Oncology plc 15 Million USD 79.825%
Biora Therapeutics, Inc. 47.42 Million USD 93.615%
PaxMedica, Inc. Common Stock - USD -Infinity%
Disc Medicine, Inc. 2.1 Million USD -44.122%
Champions Oncology, Inc. 7.43 Million USD 59.246%
REGENXBIO Inc. 89.29 Million USD 96.609%
Ensysce Biosciences, Inc. 854.69 Thousand USD -254.278%
Anavex Life Sciences Corp. - USD -Infinity%
Cellectar Biosciences, Inc. 552.98 Thousand USD -447.577%
Edgewise Therapeutics, Inc. 5.41 Million USD 44.071%
Vaxart, Inc. 26.51 Million USD 88.58%
PharmaCyte Biotech, Inc. - USD -Infinity%
Aldeyra Therapeutics, Inc. 15.65 Million USD 80.661%
Cellectis S.A. 92.85 Million USD 96.739%
Longeveron Inc. 2.04 Million USD -48.359%
Repare Therapeutics Inc. 3.41 Million USD 11.202%
Sarepta Therapeutics, Inc. 1.39 Billion USD 99.783%
Inozyme Pharma, Inc. 46.59 Million USD 93.501%
Revolution Medicines, Inc. 87.94 Million USD 96.557%
Nymox Pharmaceutical Corporation 173 Thousand USD -1650.289%
Third Harmonic Bio, Inc. 3.95 Million USD 23.4%
ArriVent BioPharma, Inc. Common Stock 317 Thousand USD -855.205%
AN2 Therapeutics, Inc. - USD -Infinity%
Anixa Biosciences, Inc. 175 Thousand USD -1630.286%
Vertex Pharmaceuticals Incorporated 808.4 Million USD 99.625%
Denali Therapeutics Inc. 52.24 Million USD 94.204%
Revelation Biosciences, Inc. - USD -Infinity%
Veru Inc. 14.4 Million USD 78.98%
Corvus Pharmaceuticals, Inc. 1.37 Million USD -120.378%
Cingulate Inc. 3.13 Million USD 3.416%
Passage Bio, Inc. 26.29 Million USD 88.484%
Context Therapeutics Inc. - USD -Infinity%
Exicure, Inc. 6.66 Million USD 54.569%
Day One Biopharmaceuticals, Inc. 408 Thousand USD -642.157%
Oramed Pharmaceuticals Inc. 894 Thousand USD -238.702%
Scinai Immunotherapeutics Ltd. 20.56 Million USD 85.273%
Rhythm Pharmaceuticals, Inc. 1.26 Million USD -140.317%
Nuvalent, Inc. - USD -Infinity%
ABVC BioPharma, Inc. 2.45 Million USD -23.535%
Carisma Therapeutics, Inc. 3.12 Million USD 3.042%
Unicycive Therapeutics, Inc. 811 Thousand USD -273.366%
OmniAb, Inc. 25.56 Million USD 88.154%
Anew Medical, Inc. 1.6 Million USD -88.66%
Fennec Pharmaceuticals Inc. 29.58 Million USD 89.764%
Lipocine Inc. 17.16 Thousand USD -17539.52%
Lexeo Therapeutics, Inc. Common Stock 11.63 Million USD 73.982%
Nautilus Biotechnology, Inc. 34.62 Million USD 91.256%
SAB Biotherapeutics, Inc. 5.9 Million USD 48.739%
G1 Therapeutics, Inc. 57.17 Million USD 94.704%
Bellerophon Therapeutics, Inc. 203 Thousand USD -1391.626%
Sage Therapeutics, Inc. 5.16 Million USD 41.375%
Ocugen, Inc. 6.94 Million USD 56.375%
Mind Medicine (MindMed) Inc. 14.12 Million USD 78.569%
Q32 Bio Inc. 1.31 Million USD -129.742%
Brainstorm Cell Therapeutics Inc. 672 Thousand USD -350.595%
Alumis Inc. Common Stock 32.58 Million USD 90.706%
Equillium, Inc. 824 Thousand USD -267.476%
Kyverna Therapeutics, Inc. 9.07 Million USD 66.648%
Coya Therapeutics, Inc. - USD -Infinity%
CNS Pharmaceuticals, Inc. 300.8 Thousand USD -906.629%
Galera Therapeutics, Inc. 152.29 Million USD 98.012%
Evelo Biosciences, Inc. 51.13 Million USD 94.079%
Comera Life Sciences Holdings, Inc. 775.04 Thousand USD -290.685%
Edesa Biotech, Inc. 94.48 Thousand USD -3104.674%
vTv Therapeutics Inc. 529 Thousand USD -472.401%
Bio-Techne Corporation 419.53 Million USD 99.278%
Agios Pharmaceuticals, Inc. 71.99 Million USD 95.794%
Harmony Biosciences Holdings, Inc. 193.56 Million USD 98.436%
Prelude Therapeutics Incorporated 16.88 Million USD 82.07%
Candel Therapeutics, Inc. 22.76 Million USD 86.697%
iTeos Therapeutics, Inc. 6.05 Million USD 50.017%
Nkarta, Inc. 88.33 Million USD 96.572%
BioCardia, Inc. 1.31 Million USD -130.266%
Iterum Therapeutics plc 19.5 Million USD 84.479%